Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
As in another CRL to beat the PPS down further with the ugly stick?
CEO has absolutely failed in this regard and yet current comp incentivizes him to keep it down.
Plenty of shade thrown on Carter over the years. He was terrible.
How many times were SEC filings amended under Carter? One time at a public company is enough to diminish trust in leadership let alone several.
The part Where Carter wasn’t dependable was with the accounting and SEC filings. Kind of important if you are the CFO.
Remember when he lied about Mikah winding down upon becoming CEO as now they own how much of our Adderall line? Where is the CEO after this was clearly not even close to the truth? Oh yeah, he’s still the CEO and not in prison.
Lawsuits yes, but not prison. In a legally frivolous society one can sue for anything and everything.
“It hasn’t been discussed…”. This is past tense.
This in no way excludes a future scenario of such. The pursuit of going private is probably less work than to be acquired by another party, especially since the CEO continues to get paid in shares increasing ownership month after month.
Lol. Seriously, on what legal grounds? Because a share price was stated for the poison pill at one time many years ago based on the business performance and expectations at that time? Like before SequestOx failed miserably?
There would be no law broken whatsoever. What has been said in the past during a conference call is protected by Safe Harbor as forward looking language. Doesn’t mean it will happen, but it could, and there would be no risk for jail. Nice imagination though.
He could buy out the company for 4 cents tomorrow if the majority of shareholders approve. With his significant ownership it wouldn’t take much more than his ownership to approve the vote.
Don’t you love safe harbor language?
These are basic SEC filing standards. Take it up with the SEC.
We have previously received news of a CRL in a quarterly SEC filing, but that could have just been timing as there was no separate release.
Assuming no delay for the K, we’re about a month away from the call and filing.
Not at all, just a lack of reality.
Another asinine comment that is so fictitious it has no basis of reality.
Man up? They are his shares. What a ridiculous request.
How do you fire the largest shareholder? Usually they are the CEO or heavily influence a company with multiple board seats.
Prior CFOs attempt at completing their job has been questionable. Count the number of amended filings.
FYI - Successful companies turn down profit all the time. One example is using capex ratios and prioritize projects based on allocating limited resources for the best returns knowing some projects that would be profitable aren’t pursued.
And yet a fraction of Lannett’s and Elite’s Adderall revenue.
Your insights as a boots on the ground pharmacist have been greatly appreciated.
This would take a multi-million dollar proxy war. Not going to happen for an OTC stock.
No. Don’t need bio for interim/contractors.
Usually companies do testing before filing. There is no way this would be a 2022 approval. ANDAs without issues take 10 months alone. Still have several months ahead before filing.
Could be material shortage on Elite’s end.
I think it’s all just coincidence. Elite share price will move up in time. Incredibly slowly, but surely.
That will put some pressure on stimulant-based ADHD drugs for sure.
Potentially same one that had brief stint as CFO for beauty company in NJ.
Interim as in probably a contractor.
Do you mean the difference between a contractor and full time employee?
CFO announcement? As in one from 4/18? Don’t see new 8-K.
Lots of games on OTC.
Would be great, but could be another Loxapine as well.
Last cc he said first half. We have zero insights as to what it is or magnitude.
For several years, pre-COVID crisis, Elite was biggest or among biggest investors in anti-abuse tech. This is why they would be included in a report like this. They delayed further studies for years due to no cash flow and SequestOx debacle. All these years as still 0 anti-abuse or abuse-deterrent revenue when outstanding shares have been obliterated.
You do realize the bonus one was already approved, right? 3 will be filed late this year/early next and we have one approval in first half of the year.
No, don’t think it’s a publicly held company, but could be wrong. There was an 8K over past couple of years as there was some confusion on the same topic. Looked like Elite was investing in a certain area, when it was a separate similarly named company.